Minireviews
Copyright ©The Author(s) 2022.
World J Hepatol. Aug 27, 2022; 14(8): 1550-1561
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1550
Table 1 Summary of study characteristics of all included studies in the literature review
No
Ref.
Definition of HP
PHH, n (%)
NP, n (%)
Type of liver resection (%)
Histopathology (%)
Post-operative phosphate replacement regime
Phosphate replacement, n (%)
1Buell et al[14], 1998< 2.5 mg/dL21/35 (60)14/35 (40)Major hepatectomy (NR); Cryosurgery (NR)CRLM: 8 (23) HCC: 4 (11) Others: 23 (66) For phosphate < 3.0 mg/dL: sodium phosphate or potassium phosphate HP: mean of 15 mmol/d on POD1, to 25 mmol/d on POD3 NP: mean of 5 mmol/dNR
2George et al[11], 1992NR44/44 (100)0Right hepatectomy and extended right hepatectomy NRNRNR
3Giovannini et al[12], 2002Normal: > 2.5 mg/dL; Mild-moderate: 1.6-2.5 mg/dL; Severe: < 1.5 mg/dL38/59 (64.4)21/59 (35.6)Major hepatectomy (58); Minor hepatectomy (42)CRLM: 10 (17) ICC: 7 (12) HCC: 16 (27) GBC: 2 (3) Others: 24 (41)If > POD3 and oral feeding cannot be resumed: parenteral phosphate (fructose 1-6 diphosphate or potassium phosphate) at 20-50 mmol/dNR
4Hallet et al[10], 2016≤ 0.65 mmol/L223/402 (55.5)179/402 (44.5)Major hepatectomy (52) Minor (48) HepatectomyCRLM: 260 (65) ICC: 53 (13) HCC: 27 (7)Others: 62 (15)Based on serum phosphate: Intravenous potassium phosphate or sodium phosphateNR
5Serrano et al[38], 2019Normal: > 2.5 mg/dL; Mild: 1.6-2.5 mg/dL; Moderate: 1.0-1.5 mg/dL; Severe: < 1.0 mg/dL161Living donor hepatectomyNAElemental phosphate based on phosphate levels: < 1.1 mg/dL: 25 mmol 1.1-1.9 mg/dL: 20 mmol 2.0-2.3 mg/dL: 15 mmol 2.4-2.7 mg/ dL: 10 mmolNR
6Squires et al[13], 2014Normal: > 2.5 mg/dL; Mild: 1.6-2.5 mg/dL; Moderate: 1.0-1.5 mg/dL; Severe: < 1.0 mg/dL488/719 (67.9)231/719 (32.1)Extended left hepatectomy (6) Extended right hepatectomy (20) Left hemihepatectomy (23) Right hemihepatectomy (39) Central hepatectomy (2) Non-anatomical (10)CRML: 229 (32) HCC: 69 (9) ICC: 88 (12) Metastatic NET: 34 (5) Other: 299 (42)Discretion of surgeon Median replacement: 55 mmol (range 10-170 mmol)469 (69)
7Tan et al[39], 2003Normal: > 2.5 mg/dL; Moderate: 1.5-2.5 mg/dL; Severe: 1.0-1.5 mg/dL; Profound: < 1.0 mg/dL89/95 (93.7)6/95 (6.3)Right-lobe living donor hepatectomy: Right hepatectomy (94); Left lateral segmentectomy (5); Left lobectomy (11)NABased on phosphate deficit: intravenous or oral phosphateNR
8Yuan et al[40], 2010Normal: > 2.5 mg/dL; Mild: 1.5-2.5 mg/dL; Moderate: 1.0-1.5 mg/dL; Severe: < 1.0 mg/dLOverall: 100/102 (98) Mild: 56/102 Moderate: 25/102 Severe: 19/1022/102 (2)Living donor hemi-hepatectomyNASevere HP: Intravenous phosphate7/19 (36.8)
Table 2 Summary of laboratory values and post-operative outcomes comparing patients with post-hepatectomy hypophosphatemia and normophosphatemia
Mean nadir phosphate, mg/dLa
Mean INRa
Length of stay, d
Post-hepatectomy liver failure
Any morbidity
30 d mortality
No
Ref.
PHH
NP
P value
PHH
NP
P value
PHH
NP
P value
PHH
NP
P value
PHH
NP
P value
PHH
NP
P value
1Buell et al[14], 19982.1 ± 0.1b 3.0 ± 0.2b < 0.05NR16.22 ± 12.0911.22 ± 7.03NRNR17/21 (81)4/14 (29)< 0.051/21 (5)0/14 (0)NR
2George et al[11], 1992NRNRNR1/44 (2)0/0NA11/44 (25)0/0 (0)NANR
3Giovannini et al[12], 20021.7 ± 0.8 (POD3)NRNRNRNRMild-moderate: 4/23 (17) Severe: 9/15 (60)3/21 (14)< 0.001cMild-moderate: 1/23 (4) Severe: 3/12 (20)1/21 (5)NR
4Hallet et al[10], 20161.52 ± 0.31d 2.72 ± 0.74d< 0.011.51 ± 0.371.53 ± 0.910.837 (6-10)7 (5-11)0.5544/223 (19.7)20/179 (11.2)0.02Major morbidity: 13/223 (5.8)Major morbidity: 12/179 (6.7)0.569/223 (4.0)4/179 (2.2)0.31
5Serrano et al[38], 20192.00e (recorded at median 1.6 d post-operatively)NR7.2 ± 3.4eNR10/161 (6.2)NRAny morbidity > 30 d: 19/161 (11.8)NRNR
6Squires et al[13], 20142.2 [1.7-2.8]NRNR Moderate: 8.0% Severe: 8.5% Profound: 3.4%f12.3%f0.008Major morbidity: Moderate: 20.1% Severe: 19.5% Profound: 16.7%f30.3%f0.037Moderate: 3.8% Severe: 2.8% Profound: 0%6.5%0.010
7Tan et al[39], 20032.6 (range 1.3-5.0)NRNRNRNRAny morbidity: 8/95 (8.4)NRNR
8Yuan et al[40], 20101.89 ± 0.72 (POD3)NRMild: 1.51 ± 0.26 Moderate: 1.43 ± 0.19 Severe: 1.95 ± 0.40NR< 0.001gNR14/100 (14)0/2 (0)NRNRNR
Table 3 Summary of phosphate replacement regimes for hypophosphatemia
Indications
Formulation
Route of administration
Composition
Recommended dosage
Special considerations
Mild hypophosphatemia (0.65-0.81 mmol/L)Phospho-soda (C.B. Fleet Company, Virginia)Oral180mg Na2HPO4 · 7H2O + 480 mg NaH2PO4 · H2O/mL Phosphate: 4.150 mmol/mL Sodium: 4.822 mEq/mL Potassium: 01000mg/dChronic renal failure / reduced glomerular filtration rate: to use half of recommended initial dose Causes diarrhoea
Phospha 250 Neutral (Rising Pharmaceuticals, Inc., United States)OralElemental phosphorus 250 mg (8 mmol), Sodium 298 mg (13 mEq), and Potassium 45 mg (1.1 mEq)
Moderate hypophosphatemia (0.32-0.65 mmol/L)Not on ventilatorPhospho-soda (C.B. Fleet Company, Virginia)(same as above)(same as above)If ≥1.5 mg/dL: 1 mmol/kg of elemental phosphorus (minimum of 40 mmol and a maximum of 80 mmol) in 3-4 doses over 24 h If < 1.5 mg/dL: 1.3 mmol/kg of elemental phosphorus (maximum of 100 mmol) in 3-4 doses over 24 h(same as above)
On ventilatorSodium phosphate (Abbott Laboratories, North Chicago, Illinois)Intravenous142 mg Na2HPO4 + 276 mg NaH2PO4 · H2O/mL Phosphate: 3.0 mmol/mL Sodium: 4.0 mEq/mL0.08 mg/kg over 2-6 h if recent and uncomplicated HP 0.16 mg/kg over 2-6 h if prolonged and has multiple causes Maximum of 20 mmol/hChronic renal failure / reduced glomerular filtration rate: to use half of recommended initial dose
Potassium phosphate (Invenex Pharmaceuticals, Grand Island, New York)236 mg K2HPO4 + 224 mg KH2PO4/mL Phosphate: 3.003 mmol/mL 4.360 mEq/mLChronic renal failure / reduced glomerular filtration rate: to use half of recommended initial dose To avoid if potassium > 4mmol/L
Severe hypophosphatemia (< 0.32 mmol/L) / Critically ill patients, or with severe complications of hypophosphatemiaSodium phosphate or potassium phospahte(same as above)(same as above)0.08-0.16 mg/kg over 2-6 h(same as above)